Attenuation of response to serotonin reuptake inhibitors.
Goldberg
J F
JF
Sacks
M H
MH
Kocsis
J H
JH
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D020280:Sertraline
D015057:1-Naphthylamine; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline